Intellectual Property India Publishes Patent Application for 'Hybrid Oligonucleotides' Filed by Entrada Therapeutics, Inc.

MUMBAI, India, Feb. 21 -- Intellectual Property India has published a patent application (202517007262 A) filed by Entrada Therapeutics, Inc., Boston, on Jan. 29, for 'hybrid oligonucleotides.'

Inventor(s) include Nowak, Ireneusz; Qian, Ziqing; and Kheirabadi, Mahboubeh.

The application for the patent was published on Feb. 21, under issue no. 08/2025.

According to the abstract released by the Intellectual Property India: "Provided herein are methods for making hybrid oligonucleotides, hybrid oligonucleotides, and compounds and compositions comprising hybrid oligonucleotides."

The patent application was internationally filed on July 13, 2023, under International application No.PCT/US2023/070154.

Disclaimer: Curated by HT Syndication....